External sources of vancomycin-resistant enterococci for intensive care units

被引:37
作者
Bonten, MJM [1 ]
Slaughter, S
Hayden, MK
Nathan, C
van Voorhis, J
Weinstein, RA
机构
[1] Cook Cty Hosp, Dept Med, Div Infect Dis, Chicago, IL 60612 USA
[2] Rush Med Coll, Chicago, IL 60612 USA
关键词
enterococci; vancomycin; antibiotic resistance; intensive care unit; colonization; epidemiology; infection control;
D O I
10.1097/00003246-199812000-00029
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: The incidence of colonization and infection with vancomycin-resistant enterococci (VRE) has increased dramatically in the last 5 yrs, especially in intensive care units (ICUs). We studied VRE-colonization in patients on admission to a medical ICU (MICU) where VRE colonization is endemic. Design: Prospective, descriptive analysis. Setting: An MICU of a public hospital. Patients: Three hundred and one consecutively admitted patients. Measurements and Main Results: Rectal swabs were obtained on admission from all patients. VRE isolates from all colonized patients were genetically fingerprinted by pulsed-field gel-electrophoresis (PFGE). Forty-three (14%) of 301 patients were colonized with VRE on MICU admission. Three (7%) of these 43 patients were admitted directly from the community without prior hospital contact, Risk of colonization on admission was related to the length of stay in the hospital before MICU-admission (odds ratio 4.65 for patients with a stay of at least 3 days) and previous in-hospital use of antibiotics, Of 22 VRE PFGE strain types recognized in the MICU during the study period, four (18%) were introduced by patients admitted directly from the community and ten (45%) were introduced by patients admitted from other hospital wards, Conclusions: These results show that although ICUs are considered epicenters for antibiotic resistance, sources extraneous to our MICU (e.g., other wards) contributed the majority of VRE strain types in the unit.
引用
收藏
页码:2001 / 2004
页数:4
相关论文
共 25 条
[1]
[Anonymous], 1993, M7A3 NCCLS
[2]
EVIDENCE FOR AN ANIMAL ORIGIN OF VANCOMYCIN-RESISTANT ENTEROCOCCI [J].
BATES, J ;
JORDENS, Z ;
SELKON, JB .
LANCET, 1993, 342 (8869) :490-491
[3]
FARM-ANIMALS AS A PUTATIVE RESERVOIR FOR VANCOMYCIN-RESISTANT ENTEROCOCCAL INFECTION IN MAN [J].
BATES, J ;
JORDENS, JZ ;
GRIFFITHS, DT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (04) :507-514
[4]
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci [J].
Bonten, MJM ;
Hayden, MK ;
Nathan, C ;
vanVoorhis, J ;
Matushek, M ;
Slaughter, S ;
Rice, T ;
Weinstein, RA .
LANCET, 1996, 348 (9042) :1615-1619
[5]
OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].
BOYCE, JM ;
OPAL, SM ;
CHOW, JW ;
ZERVOS, MJ ;
POTTERBYNOE, G ;
SHERMAN, CB ;
ROMULO, RLC ;
FORTNA, S ;
MEDEIROS, AA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153
[6]
EPIDEMIOLOGIC ANALYSIS AND GENOTYPIC CHARACTERIZATION OF A NOSOCOMIAL OUTBREAK OF VANCOMYCIN-RESISTANT ENTEROCOCCI [J].
BOYLE, JF ;
SOUMAKIS, SA ;
RENDO, A ;
HERRINGTON, JA ;
GIANARKIS, DG ;
THURBERG, BE ;
PAINTER, BG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (05) :1280-1285
[7]
BYERS KE, 1996, INFECT CONT HOSP EP, V17, pP18
[8]
CDC, 1993, MMWR-MORBID MORTAL W, V42, P597
[9]
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States [J].
Coque, TM ;
Tomayko, JF ;
Ricke, SC ;
Okhyusen, PC ;
Murray, BE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2605-2609
[10]
VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133